EUVIMEDEUVIMED entdecken
Crossref

Small proline-rich protein 1A promotes lung adenocarcinoma progression and indicates unfavorable clinical outcomes

Shenqi Wang, Wenmei Zhang iD

Biochemistry and Cell Biology · 01.06.2022 · 100 (3) · 199-212

DOI: 10.1139/bcb-2021-0348 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemistry and Cell Biology, erschienen am 01.06.2022. Verfasst von Shenqi Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200336, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Cornified Envelope Proline-Rich Proteins, Lung Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Small proline-rich protein 1A (SPRR1A) plays a critical role in regulating squamous cell differentiation. SPRR1A overexpression was reported to be closely related to the progression of some tumors, such as gastric cancer and colon cancer. However, the function of SPRR1A in lung adenocarcinoma (LUAD) has not been elucidated. Here, we first examined the expression pattern of SPRR1A in LUAD tissues, which indicated that the SPRR1A expression level was significantly elevated in LUAD tissues compared with normal lung tissues. High expression of SPRR1A was closely related to larger tumor size. LUAD patients with higher SPRR1A expression had poorer overall survival and SPRR1A was identified as an independent unfavorable prognosis factor. In addition, the effects of SPRR1A on lung cancer cells were tested through cellular experiments and the result demonstrated that knockdown of SPRR1A can suppress the proliferation and invasion capacities of tumor cells, while overexpressing SPRR1A exerted opposite effects. Finally, our findings were substantiated by the data obtained from in vivo xenografts using a mice model. In conclusion, LUAD patients with higher SPRR1A expression were more predisposed to poorer clinical outcomes and unfavorable prognoses, indicating the potential role of SPRR1A as a novel clinical biomarker and therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungCornified Envelope Proline-Rich ProteinsLung NeoplasmsAnimalsCell ProliferationGene Expression Regulation, NeoplasticHumansLungMice

Stichwörter der Autor:innen

adénocarcinome pulmonaireinvasionlung adenocarcinomapetite protéine riche en proline 1Aprognosisproliferationproliférationpronosticsmall proline-rich protein 1A

Substanzen

Cornified Envelope Proline-Rich ProteinsSPRR1A protein, human

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200336, China.

ORCID-Profile: Wenmei Zhang

Zitieren

APA

Wang, S., & Zhang, W. (2022). Small proline-rich protein 1A promotes lung adenocarcinoma progression and indicates unfavorable clinical outcomes. Biochemistry and Cell Biology, 100(3), 199-212. https://doi.org/10.1139/bcb-2021-0348

Vancouver

Wang S, Zhang W. Small proline-rich protein 1A promotes lung adenocarcinoma progression and indicates unfavorable clinical outcomes. Biochemistry and Cell Biology. 2022;100(3):199-212. doi:10.1139/bcb-2021-0348

BibTeX
@article{Wang2022,
  author = {Wang, Shenqi and Zhang, Wenmei},
  title = {Small proline-rich protein 1A promotes lung adenocarcinoma progression and indicates unfavorable clinical outcomes},
  journal = {Biochemistry and Cell Biology},
  year = {2022},
  volume = {100},
  number = {3},
  pages = {199--212},
  doi = {10.1139/bcb-2021-0348}
}
Kostenlos starten →